16.05.2023 - Appointed Jeffrey Kindler, J.D. and John Maraganore, Ph.D. as strategy and business advisors to the CompanyPITTSBURGH, May 16, 2023 (GLOBE NEWSWIRE) - NeuBase Therapeutics, Inc. (Nasdaq: NBSE) (“NeuBase” or the “Company”), a biotechnology company . Seite 1